Source: GWASCAT

Gene Gene Full Name DSI g DPI g pLI Disease Type Score gda EL gda EI gda N. PMIDs N. SNPs gda First Ref. Last Ref.
Entrez Id: 55576
Gene Symbol: STAB2
STAB2 		stabilin 2 0.743 0.423 9.2E-62
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 284217
Gene Symbol: LAMA1
LAMA1 		laminin subunit alpha 1 0.582 0.808 3.2E-32
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 200403
Gene Symbol: VWA3B
VWA3B 		von Willebrand factor A domain containing 3B 0.729 0.154 9.7E-28
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 286749
Gene Symbol: STON1-GTF2A1L
STON1-GTF2A1L 		STON1-GTF2A1L readthrough 0.682 0.385 1.5E-22
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 8379
Gene Symbol: MAD1L1
MAD1L1 		mitotic arrest deficient 1 like 1 0.570 0.731 6.8E-16
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 7373
Gene Symbol: COL14A1
COL14A1 		collagen type XIV alpha 1 chain 0.674 0.615 1.4E-14
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 1305
Gene Symbol: COL13A1
COL13A1 		collagen type XIII alpha 1 chain 0.608 0.654 3.7E-14
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 29119
Gene Symbol: CTNNA3
CTNNA3 		catenin alpha 3 0.612 0.692 1.0E-12
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 55199
Gene Symbol: FAM86C1
FAM86C1 		family with sequence similarity 86 member C1 0.931 0.077 5.6E-12
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 11037
Gene Symbol: STON1
STON1 		stonin 1 0.729 0.308 1.5E-11
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 27165
Gene Symbol: GLS2
GLS2 		glutaminase 2 0.597 0.538 1.3E-10
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 54898
Gene Symbol: ELOVL2
ELOVL2 		ELOVL fatty acid elongase 2 0.722 0.423 8.4E-10
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 4507
Gene Symbol: MTAP
MTAP 		methylthioadenosine phosphorylase 0.514 0.731 7.6E-08
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 53353
Gene Symbol: LRP1B
LRP1B 		LDL receptor related protein 1B 0.626 0.615 2.5E-06
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 9420
Gene Symbol: CYP7B1
CYP7B1 		cytochrome P450 family 7 subfamily B member 1 0.563 0.692 3.3E-06
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 55297
Gene Symbol: CCDC91
CCDC91 		coiled-coil domain containing 91 0.729 0.423 3.8E-06
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 22920
Gene Symbol: KIFAP3
KIFAP3 		kinesin associated protein 3 0.760 0.346 1.6E-05
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 30844
Gene Symbol: EHD4
EHD4 		EH domain containing 4 0.931 0.115 4.2E-05
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 1060
Gene Symbol: CENPC
CENPC 		centromere protein C 0.743 0.538 7.4E-05
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 23671
Gene Symbol: TMEFF2
TMEFF2 		transmembrane protein with EGF like and two follistatin like domains 2 0.619 0.500 7.4E-05
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 9150
Gene Symbol: CTDP1
CTDP1 		CTD phosphatase subunit 1 0.641 0.577 6.0E-04
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 6014
Gene Symbol: RIT2
RIT2 		Ras like without CAAX 2 0.647 0.538 6.3E-04
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 100527978
Gene Symbol: TLCD4-RWDD3
TLCD4-RWDD3 		TLCD4-RWDD3 readthrough 0.931 0.038 8.2E-03
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 2070
Gene Symbol: EYA4
EYA4 		EYA transcriptional coactivator and phosphatase 4 0.604 0.615 4.9E-02
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019
Entrez Id: 80206
Gene Symbol: FHOD3
FHOD3 		formin homology 2 domain containing 3 0.722 0.346 6.7E-02
CUI: C0869220
Disease: Adverse effects, not elsewhere classified
Adverse effects, not elsewhere classified 		disease 0.100 None 1.000 1 1 2019 2019